Platinum Equity announced that it has signed a definitive agreement to acquire Solenis, a global producer of specialty chemicals used in water-intensive industries, from Clayton, Dubilier & Rice and BASF in a transaction that implies
Tags :Andreas Müller
Grünenthal announced the acquisition of Mestex through the purchase of all of its shares and outstanding options. Mestex is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the
VectivBio Holding AG announced its initial public offering and listing of its shares on Nasdaq (ticker symbol VECT). VectivBio is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments
The team included partner Andreas Müller, lead associate (pictured) Anna Peter and junior associate Philipp Stiegeler (all Corporate / M&A), associate Valentin Fluor (IP / IT and Data Protection), partner Jürg Frick, associates Stefan
Homburger advises VectivBio on USD 110 m crossover financing.The team was led by partner Andreas Müller (pictured left). Walder Wyss advised BPI France, Cowen Healthcare Investments, Novo Ventures, OrbiMed and Versant Ventures as lead
The team also advised on Durfy's CHF 250 m equity investment commitment in the context of the planned CHF 700 m rights offering
The team was led by partners Frank Gerhard (pictured) and Andreas Müller and comprised associates Marc Hanslin and Carlo Sulser and junior associate Daniel Madani (all Capital Markets, Corporate/M&A) as well as
Homburger advises Dufry on the planned acquisition of all remaining equity interest in Hudson and the related equity financing
The team was led by partner Andreas Müller (Corporate/M&A, Technology and Digital Economy - pictured) and included partners Richard Stäuber
Niederer Kraft Frey acted as legal counsel to the selling shareholders. Homburger advised Silversmith Capital Partners and Appfire Technologies in this transaction.
